|
SHCBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.105000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.272000E-01 |
| Normal-vs-Stage2 |
4.286000E-02 |
| Normal-vs-Stage3 |
1.614450E-01 |
| Normal-vs-Stage4 |
1.796950E-01 |
| Stage1-vs-Stage2 |
1.175320E-03 |
| Stage1-vs-Stage3 |
1.988220E-01 |
| Stage1-vs-Stage4 |
3.042600E-01 |
| Stage2-vs-Stage3 |
5.548300E-02 |
| Stage2-vs-Stage4 |
7.509600E-02 |
| Stage3-vs-Stage4 |
9.241200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.141400E-01 |
| Normal-vs-AfricanAmerican |
6.554000E-02 |
| Normal-vs-Asian |
2.016400E-01 |
| Caucasian-vs-AfricanAmerican |
1.794200E-02 |
| Caucasian-vs-Asian |
4.085000E-01 |
| AfricanAmerican-vs-Asian |
1.997790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.826840E-01 |
| Normal-vs-Female |
2.260800E-01 |
| Male-vs-Female |
6.443000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.495000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.204990E-01 |
| Normal-vs-Age(61-80Yrs) |
1.850410E-01 |
| Normal-vs-Age(81-100Yrs) |
8.022000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.627600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.547610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.272600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.116770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.162040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.197000E-01 |
| Classical-VS-Follicular |
4.656200E-01 |
| Classical-VS-Other |
3.635900E-02 |
| Classical-VS-Normal |
2.409800E-01 |
| Tall-VS-Follicular |
3.801800E-01 |
| Tall-VS-Other |
8.924000E-02 |
| Tall-VS-Normal |
4.617200E-01 |
| Follicular-VS-Other |
4.193200E-01 |
| Follicular-VS-Normal |
1.614770E-01 |
| Other-VS-Normal |
4.863500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.802770E-01 |
| Normal-vs-N1 |
1.005970E-01 |
| N0-vs-N1 |
3.767200E-01 |
|
|
